Stigma and health-related quality of life (HRQoL) among people with multidrug-resistant tuberculosis (MDR-TB): A cross-sectional study in Indonesia.

Narra J Pub Date : 2025-08-01 Epub Date: 2025-04-21 DOI:10.52225/narra.v5i2.1317
Bustanul Arifin, Muhamad G Sarwadan, Elly Wahyudin, Latifah M Sarifah, Ahmad Fuady, Fredrick D Purba, Sylmina D Alkaff, Akhmad Ardiansyah, Jamaluddin Madolangan
{"title":"Stigma and health-related quality of life (HRQoL) among people with multidrug-resistant tuberculosis (MDR-TB): A cross-sectional study in Indonesia.","authors":"Bustanul Arifin, Muhamad G Sarwadan, Elly Wahyudin, Latifah M Sarifah, Ahmad Fuady, Fredrick D Purba, Sylmina D Alkaff, Akhmad Ardiansyah, Jamaluddin Madolangan","doi":"10.52225/narra.v5i2.1317","DOIUrl":null,"url":null,"abstract":"<p><p>Stigma often accompanies people with multidrug-resistant tuberculosis (MDR-TB) and potentially affects their health-related quality of life (HRQoL). The aim of this study was to investigate the stigma faced by patients with MDR-TB, both from the patients' and community's perspective, and its relationship with HRQoL. Data was gathered at the provincial hospital in Makassar, South Sulawesi, Indonesia. The instrument employed in this research was the Indonesian version of the tuberculosis (TB) stigma instrument to assess MDR-TB stigma from the patient and community perspectives. The patient perspective represents how individuals with TB perceive and experience stigma, including the fear of disclosure, isolation, and guilt (feeling responsible for the burden on their family or their own risky behaviors). Meanwhile, the community perspective reflects how individuals with TB perceive societal attitudes towards them, such as social distancing, avoidance, and reluctance to interact. HRQoL was measured using the European quality of life-5 dimensions-5 level version (EQ-5D-5L) instrument. Notably, the evaluation of anxiety and depression is centered on the fifth dimension of the EQ-5D-5L instrument. A total of 210 patients with MDR-TB were included in the study, all of whom reported experiencing stigma. Most participants perceived stigma at a moderate level, with 76% from the patient perspective and 71% from the community perspective. The average EQ-5D-5L index score was 0.72 (95% confidence interval (95%CI): 0.68-0.76). Measurements from both perspectives show similar scores. There is a substantial negative association between the level of stigma and HRQoL, both from the patient's perspective (<i>R</i> <sup>2</sup>=-0.33; F=102.52; <i>p</i><0.001) and the community's (<i>R</i> <sup>2</sup>=-0.32; F=96.76; <i>p</i><0.001). The study highlights that the stigma of MDR-TB significantly affects the HRQoL from the patient and community perspective.</p>","PeriodicalId":517416,"journal":{"name":"Narra J","volume":"5 2","pages":"e1317"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12425512/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Narra J","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52225/narra.v5i2.1317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Stigma often accompanies people with multidrug-resistant tuberculosis (MDR-TB) and potentially affects their health-related quality of life (HRQoL). The aim of this study was to investigate the stigma faced by patients with MDR-TB, both from the patients' and community's perspective, and its relationship with HRQoL. Data was gathered at the provincial hospital in Makassar, South Sulawesi, Indonesia. The instrument employed in this research was the Indonesian version of the tuberculosis (TB) stigma instrument to assess MDR-TB stigma from the patient and community perspectives. The patient perspective represents how individuals with TB perceive and experience stigma, including the fear of disclosure, isolation, and guilt (feeling responsible for the burden on their family or their own risky behaviors). Meanwhile, the community perspective reflects how individuals with TB perceive societal attitudes towards them, such as social distancing, avoidance, and reluctance to interact. HRQoL was measured using the European quality of life-5 dimensions-5 level version (EQ-5D-5L) instrument. Notably, the evaluation of anxiety and depression is centered on the fifth dimension of the EQ-5D-5L instrument. A total of 210 patients with MDR-TB were included in the study, all of whom reported experiencing stigma. Most participants perceived stigma at a moderate level, with 76% from the patient perspective and 71% from the community perspective. The average EQ-5D-5L index score was 0.72 (95% confidence interval (95%CI): 0.68-0.76). Measurements from both perspectives show similar scores. There is a substantial negative association between the level of stigma and HRQoL, both from the patient's perspective (R 2=-0.33; F=102.52; p<0.001) and the community's (R 2=-0.32; F=96.76; p<0.001). The study highlights that the stigma of MDR-TB significantly affects the HRQoL from the patient and community perspective.

耐多药结核病(MDR-TB)患者的耻辱感与健康相关生活质量(HRQoL):印度尼西亚的一项横断面研究
病耻感往往伴随着耐多药结核病患者,并可能影响他们与健康相关的生活质量。本研究的目的是从患者和社区的角度探讨耐多药结核病患者面临的耻辱感及其与HRQoL的关系。数据是在印度尼西亚南苏拉威西望加锡省医院收集的。本研究使用的工具是印尼版结核病病耻感量表,从患者和社区的角度评估耐多药结核病病耻感。​同时,社区视角反映了结核病患者如何看待社会对他们的态度,如保持社会距离、回避和不愿互动。HRQoL采用欧洲生活质量5维5级量表(EQ-5D-5L)测量。值得注意的是,焦虑和抑郁的评估集中在EQ-5D-5L量表的第五个维度上。共有210名耐多药结核病患者被纳入该研究,所有患者都报告经历了耻辱感。大多数参与者认为耻辱程度中等,76%的人从患者角度出发,71%的人从社区角度出发。EQ-5D-5L指数平均得分为0.72(95%可信区间(95% ci): 0.68-0.76)。从两种角度进行的测量显示出相似的分数。从患者的角度来看,耻感水平与HRQoL之间存在显著的负相关(r2 =-0.33; F=102.52; pR 2=-0.32; F=96.76; p
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信